Testosterone Undecanoate vs Cypionate: Which Is Right for TRT?

Testosterone Undecanoate vs Cypionate: Very Different Pharmacokinetics

Testosterone undecanoate (Aveed® in the US, Nebido® in Europe) and testosterone cypionate represent two ends of the injection frequency spectrum for TRT. Testosterone undecanoate has an extremely long half-life of approximately 21 days — making it one of the longest-acting injectable testosterone preparations available. The Aveed® injection protocol in the US involves injections every 10 weeks after an initial loading period. Testosterone cypionate requires weekly or biweekly injections.

For Tmates' approach to weight loss's TRT program ($200/mo, labs included), testosterone cypionate is used because of a combination of clinical and practical advantages over undecanoate. Aveed® requires a specific risk evaluation and mitigation strategy (REMS) due to pulmonary oil microembolism risk following intramuscular injection — a safety requirement that limits its administration to clinic settings with observation periods. Weekly subcutaneous testosterone cypionate injections can be self-administered at home safely, which is essential for a telehealth program.

Testosterone undecanoate's primary advantage — very infrequent injections — doesn't apply in a home-based program where weekly subcutaneous injections are well-tolerated by most patients. Cypionate's weekly protocol also allows faster dose adjustment based on lab results: if your first labs show sub-optimal levels, the next week's injection can be adjusted. With undecanoate's 10-week interval, adjustments take months to evaluate. Tmates' included lab work monitors your cypionate dosing continuously, enabling precise optimization. Explore the full men's health category and compare: cypionate vs Sustanon, cypionate vs propionate, how long to work.